| In Focus Eyecare P.c. | |
|
750 S Randall Rd, Algonquin, IL 60102-5915 | |
| (847) 458-5343 | |
| (847) 458-5344 |
| Full Name | In Focus Eyecare P.c. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 750 S Randall Rd, Algonquin, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053723908 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 046010021 (Illinois) | Primary |
| Provider Name | Jerilyn K Prybell |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1295814572 PECOS PAC ID: 9335140458 Enrollment ID: I20070116000370 |
News Archive
Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.
Dr. Joseph Bresee, chief of the epidemiology prevention branch at the influenza division at the Centers for Disease Control and Prevention (CDC), said for the third consecutive week this season the percent of respiratory specimen testing positive for flu surpassed 10 percent, which is generally a marker to indicate the flu season has begun. "This is the latest start to a flu season in the past 29 years," said Dr. Bresee.
According to a recent IMS Health study, poor medication use by clinicians and patients costs $200 billion each year in the U.S., or 8 percent of all U.S. healthcare expenditures. To improve medication use and safety, MedSnap, LLC introduces MedSnap ID, an iPhone application for clinicians, health systems, hospitals, clinics, ACOs, pharmacies and home health providers.
While surgical outcomes have improved nationally over time, surgical outcome reporting does not necessarily lead to better outcomes, according to a Mayo Clinic study published this week in the Journal of the American Medical Association.
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
› Verified 2 days ago
| Provider Name | Amna M Malik |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1154389963 PECOS PAC ID: 8325065402 Enrollment ID: I20080115000288 |
News Archive
Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.
Dr. Joseph Bresee, chief of the epidemiology prevention branch at the influenza division at the Centers for Disease Control and Prevention (CDC), said for the third consecutive week this season the percent of respiratory specimen testing positive for flu surpassed 10 percent, which is generally a marker to indicate the flu season has begun. "This is the latest start to a flu season in the past 29 years," said Dr. Bresee.
According to a recent IMS Health study, poor medication use by clinicians and patients costs $200 billion each year in the U.S., or 8 percent of all U.S. healthcare expenditures. To improve medication use and safety, MedSnap, LLC introduces MedSnap ID, an iPhone application for clinicians, health systems, hospitals, clinics, ACOs, pharmacies and home health providers.
While surgical outcomes have improved nationally over time, surgical outcome reporting does not necessarily lead to better outcomes, according to a Mayo Clinic study published this week in the Journal of the American Medical Association.
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
› Verified 2 days ago
| Provider Name | Darry G Sommer |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1346399060 PECOS PAC ID: 8921145640 Enrollment ID: I20091028000430 |
News Archive
Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.
Dr. Joseph Bresee, chief of the epidemiology prevention branch at the influenza division at the Centers for Disease Control and Prevention (CDC), said for the third consecutive week this season the percent of respiratory specimen testing positive for flu surpassed 10 percent, which is generally a marker to indicate the flu season has begun. "This is the latest start to a flu season in the past 29 years," said Dr. Bresee.
According to a recent IMS Health study, poor medication use by clinicians and patients costs $200 billion each year in the U.S., or 8 percent of all U.S. healthcare expenditures. To improve medication use and safety, MedSnap, LLC introduces MedSnap ID, an iPhone application for clinicians, health systems, hospitals, clinics, ACOs, pharmacies and home health providers.
While surgical outcomes have improved nationally over time, surgical outcome reporting does not necessarily lead to better outcomes, according to a Mayo Clinic study published this week in the Journal of the American Medical Association.
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
› Verified 2 days ago
| Provider Name | Rocio Pena |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1871809418 PECOS PAC ID: 4981897394 Enrollment ID: I20101018001256 |
News Archive
Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.
Dr. Joseph Bresee, chief of the epidemiology prevention branch at the influenza division at the Centers for Disease Control and Prevention (CDC), said for the third consecutive week this season the percent of respiratory specimen testing positive for flu surpassed 10 percent, which is generally a marker to indicate the flu season has begun. "This is the latest start to a flu season in the past 29 years," said Dr. Bresee.
According to a recent IMS Health study, poor medication use by clinicians and patients costs $200 billion each year in the U.S., or 8 percent of all U.S. healthcare expenditures. To improve medication use and safety, MedSnap, LLC introduces MedSnap ID, an iPhone application for clinicians, health systems, hospitals, clinics, ACOs, pharmacies and home health providers.
While surgical outcomes have improved nationally over time, surgical outcome reporting does not necessarily lead to better outcomes, according to a Mayo Clinic study published this week in the Journal of the American Medical Association.
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
› Verified 2 days ago
| Provider Name | Gina C Copeland |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1396057956 PECOS PAC ID: 9234307380 Enrollment ID: I20110718000073 |
News Archive
Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.
Dr. Joseph Bresee, chief of the epidemiology prevention branch at the influenza division at the Centers for Disease Control and Prevention (CDC), said for the third consecutive week this season the percent of respiratory specimen testing positive for flu surpassed 10 percent, which is generally a marker to indicate the flu season has begun. "This is the latest start to a flu season in the past 29 years," said Dr. Bresee.
According to a recent IMS Health study, poor medication use by clinicians and patients costs $200 billion each year in the U.S., or 8 percent of all U.S. healthcare expenditures. To improve medication use and safety, MedSnap, LLC introduces MedSnap ID, an iPhone application for clinicians, health systems, hospitals, clinics, ACOs, pharmacies and home health providers.
While surgical outcomes have improved nationally over time, surgical outcome reporting does not necessarily lead to better outcomes, according to a Mayo Clinic study published this week in the Journal of the American Medical Association.
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
› Verified 2 days ago
| Provider Name | Autumn B Durias |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1841587052 PECOS PAC ID: 1052583861 Enrollment ID: I20111019000940 |
News Archive
Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.
Dr. Joseph Bresee, chief of the epidemiology prevention branch at the influenza division at the Centers for Disease Control and Prevention (CDC), said for the third consecutive week this season the percent of respiratory specimen testing positive for flu surpassed 10 percent, which is generally a marker to indicate the flu season has begun. "This is the latest start to a flu season in the past 29 years," said Dr. Bresee.
According to a recent IMS Health study, poor medication use by clinicians and patients costs $200 billion each year in the U.S., or 8 percent of all U.S. healthcare expenditures. To improve medication use and safety, MedSnap, LLC introduces MedSnap ID, an iPhone application for clinicians, health systems, hospitals, clinics, ACOs, pharmacies and home health providers.
While surgical outcomes have improved nationally over time, surgical outcome reporting does not necessarily lead to better outcomes, according to a Mayo Clinic study published this week in the Journal of the American Medical Association.
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
› Verified 2 days ago
| Provider Name | Thomas Leonard Ruiz |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1316597594 PECOS PAC ID: 9436581410 Enrollment ID: I20191112003496 |
News Archive
Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.
Dr. Joseph Bresee, chief of the epidemiology prevention branch at the influenza division at the Centers for Disease Control and Prevention (CDC), said for the third consecutive week this season the percent of respiratory specimen testing positive for flu surpassed 10 percent, which is generally a marker to indicate the flu season has begun. "This is the latest start to a flu season in the past 29 years," said Dr. Bresee.
According to a recent IMS Health study, poor medication use by clinicians and patients costs $200 billion each year in the U.S., or 8 percent of all U.S. healthcare expenditures. To improve medication use and safety, MedSnap, LLC introduces MedSnap ID, an iPhone application for clinicians, health systems, hospitals, clinics, ACOs, pharmacies and home health providers.
While surgical outcomes have improved nationally over time, surgical outcome reporting does not necessarily lead to better outcomes, according to a Mayo Clinic study published this week in the Journal of the American Medical Association.
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
› Verified 2 days ago
| Provider Name | Lananh Trinh Ngo |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1629508429 PECOS PAC ID: 0547678310 Enrollment ID: I20210415000444 |
News Archive
Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.
Dr. Joseph Bresee, chief of the epidemiology prevention branch at the influenza division at the Centers for Disease Control and Prevention (CDC), said for the third consecutive week this season the percent of respiratory specimen testing positive for flu surpassed 10 percent, which is generally a marker to indicate the flu season has begun. "This is the latest start to a flu season in the past 29 years," said Dr. Bresee.
According to a recent IMS Health study, poor medication use by clinicians and patients costs $200 billion each year in the U.S., or 8 percent of all U.S. healthcare expenditures. To improve medication use and safety, MedSnap, LLC introduces MedSnap ID, an iPhone application for clinicians, health systems, hospitals, clinics, ACOs, pharmacies and home health providers.
While surgical outcomes have improved nationally over time, surgical outcome reporting does not necessarily lead to better outcomes, according to a Mayo Clinic study published this week in the Journal of the American Medical Association.
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
› Verified 2 days ago
| Provider Name | Maria C Rodriguez |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1477273449 PECOS PAC ID: 4183088396 Enrollment ID: I20230906002974 |
News Archive
Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.
Dr. Joseph Bresee, chief of the epidemiology prevention branch at the influenza division at the Centers for Disease Control and Prevention (CDC), said for the third consecutive week this season the percent of respiratory specimen testing positive for flu surpassed 10 percent, which is generally a marker to indicate the flu season has begun. "This is the latest start to a flu season in the past 29 years," said Dr. Bresee.
According to a recent IMS Health study, poor medication use by clinicians and patients costs $200 billion each year in the U.S., or 8 percent of all U.S. healthcare expenditures. To improve medication use and safety, MedSnap, LLC introduces MedSnap ID, an iPhone application for clinicians, health systems, hospitals, clinics, ACOs, pharmacies and home health providers.
While surgical outcomes have improved nationally over time, surgical outcome reporting does not necessarily lead to better outcomes, according to a Mayo Clinic study published this week in the Journal of the American Medical Association.
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
› Verified 2 days ago
| Provider Name | Amina Haider |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1306345855 PECOS PAC ID: 8729442942 Enrollment ID: I20230906003424 |
News Archive
Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.
Dr. Joseph Bresee, chief of the epidemiology prevention branch at the influenza division at the Centers for Disease Control and Prevention (CDC), said for the third consecutive week this season the percent of respiratory specimen testing positive for flu surpassed 10 percent, which is generally a marker to indicate the flu season has begun. "This is the latest start to a flu season in the past 29 years," said Dr. Bresee.
According to a recent IMS Health study, poor medication use by clinicians and patients costs $200 billion each year in the U.S., or 8 percent of all U.S. healthcare expenditures. To improve medication use and safety, MedSnap, LLC introduces MedSnap ID, an iPhone application for clinicians, health systems, hospitals, clinics, ACOs, pharmacies and home health providers.
While surgical outcomes have improved nationally over time, surgical outcome reporting does not necessarily lead to better outcomes, according to a Mayo Clinic study published this week in the Journal of the American Medical Association.
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| In Focus Eyecare P.c. 10883 Concord Ln, Huntley, IL 60142-4041 Ph: (832) 641-3351 | In Focus Eyecare P.c. 750 S Randall Rd, Algonquin, IL 60102-5915 Ph: (847) 458-5343 |
News Archive
Texas authorities are investigating whether Xerox Corp. played a role in allowing dentists to allegedly overbill the state's Medicaid system by millions of dollars.
Dr. Joseph Bresee, chief of the epidemiology prevention branch at the influenza division at the Centers for Disease Control and Prevention (CDC), said for the third consecutive week this season the percent of respiratory specimen testing positive for flu surpassed 10 percent, which is generally a marker to indicate the flu season has begun. "This is the latest start to a flu season in the past 29 years," said Dr. Bresee.
According to a recent IMS Health study, poor medication use by clinicians and patients costs $200 billion each year in the U.S., or 8 percent of all U.S. healthcare expenditures. To improve medication use and safety, MedSnap, LLC introduces MedSnap ID, an iPhone application for clinicians, health systems, hospitals, clinics, ACOs, pharmacies and home health providers.
While surgical outcomes have improved nationally over time, surgical outcome reporting does not necessarily lead to better outcomes, according to a Mayo Clinic study published this week in the Journal of the American Medical Association.
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
› Verified 2 days ago
Dawn Wickizer Optometrist Medicare: Medicare Enrolled Practice Location: 436 S Randall Rd, Algonquin, IL 60102 Phone: 847-658-4242 Fax: 847-658-5643 | |
Wendy Jean Mchugh, OD Optometrist Medicare: Medicare Enrolled Practice Location: 245 Stonegate Rd, Algonquin, IL 60102 Phone: 847-658-0120 Fax: 847-658-0610 | |
Atkinson Eye Care, P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 2100 N. Huntington Drive, Unit A, Algonquin, IL 60102 Phone: 847-854-5700 Fax: 847-854-5762 | |
Morfoot Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 400 S Randall Rd, Algonquin, IL 60102 Phone: 847-854-5412 | |
Precision Eye Care Llc Optometrist Medicare: Medicare Enrolled Practice Location: 204 S Main St, Algonquin, IL 60102 Phone: 224-678-9043 | |
Amna Mirza Malik, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 750 S Randall Rd, Algonquin, IL 60102 Phone: 847-458-5343 Fax: 847-458-4344 |